Clinical utility of sarcopenia dynamics assessed by psoas muscle volume in patients with colorectal cancer

被引:0
|
作者
Kumamoto, Tomotaka [1 ,2 ]
Takamizawa, Yasuyuki [1 ]
Miyake, Mototaka [3 ]
Inoue, Manabu [1 ]
Moritani, Konosuke [1 ]
Tsukamoto, Shunsuke [1 ]
Eto, Ken [2 ]
Kanemitsu, Yukihide [1 ]
机构
[1] Natl Canc Ctr, Dept Colorectal Surg, 5-1-1 Tsukiji,Chuo Ku, Tokyo 1040045, Japan
[2] Jikei Univ, Sch Med, Dept Surg, Chuo Ku, Tokyo, Japan
[3] Natl Canc Ctr, Dept Diagnost Radiol, Chuo Ku, Tokyo, Japan
关键词
colorectal cancer; psoas muscle volume; sarcopenia dynamics; SKELETAL-MUSCLE; MORTALITY; RESECTION; OUTCOMES; INDEX; MASS; COMPLICATIONS; PREVALENCE; IMPACT;
D O I
10.1002/wjs.12302
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundSarcopenia affects the postoperative prognosis of patients with colorectal cancer (CRC). Recently, it has become possible to measure psoas volume from computed tomography images, and an index called psoas volume index (PVI) has been reported. However, it is unclear whether the dynamics of PVI before and after surgery is associated with clinical outcomes after CRC surgery. This study aimed to evaluate the association between pre- and postoperative PVI dynamics and clinical outcomes after CRC surgery.MethodsThis study analyzed 1115 patients diagnosed with primary CRC and operated on for treatment between January 2014 and December 2017. Sarcopenia was defined as PVI below the lowest tertile in the preoperative assessment for each sex. The overall population was divided into four groups according to the dynamics of sarcopenia from preoperative to postoperative: group 1 (pre-to postoperative sarcopenia), group 2 (preoperative nonsarcopenia to postoperative sarcopenia), group 3 (pre-to postoperative nonsarcopenia), and group 4 (pre-to postoperative nonsarcopenia).ResultsBased on pre- and postoperative sarcopenia dynamics, 343 patients (29.7%) were classified into group 1, 105 patients (9.1%) into group 2, 42 patients (3.6%) into group 3, and 665 patients (57.6%) into group 4. Comparison of overall survival (OS) by the Kaplan-Meier method showed that Group 2 tended to have the worst prognosis (p = 0.007). Multivariate analysis showed an increased OS risk in Group 2 in sarcopenia dynamics (Hazard ratio: 2.103, 95% CI: 1.202-3.681, p = 0.009).ConclusionsSarcopenia dynamics using PVI is an independent prognostic predictor of OS in patients with CRC.
引用
收藏
页码:2098 / 2108
页数:11
相关论文
共 50 条
  • [41] Psoas muscle volume is correlated with sexual activity and erectile dysfunction among patients with localised prostate cancer
    Kashiwagi, Eiji
    Imada, Kenjiro
    Monji, Keisuke
    Takeuchi, Ario
    Shiota, Masaki
    Inokuchi, Junichi
    Tatsugami, Katsunori
    Eto, Masatoshi
    ANDROLOGIA, 2019, 51 (09)
  • [42] Do psoas muscle area and volume correlate with postoperative complications in patients undergoing rectal cancer resection?
    Womer, Aaron L.
    Brady, Justin T.
    Kalisz, Kevin
    Patel, Nilam D.
    Paspulati, Raj M.
    Reynolds, Harry L.
    Pawlik, Timothy M.
    Steele, Scott R.
    AMERICAN JOURNAL OF SURGERY, 2018, 215 (03): : 503 - 506
  • [43] The association of medical and demographic characteristics with sarcopenia and low muscle radiodensity in patients with nonmetastatic colorectal cancer
    Xiao, Jingjie
    Caan, Bette J.
    Feliciano, Elizabeth M. Cespedes
    Meyerhardt, Jeffrey A.
    Kroenke, Candyce H.
    Baracos, Vickie E.
    Weltzien, Erin
    Kwan, Marilyn L.
    Alexeeff, Stacey E.
    Castillo, Adrienne L.
    Prado, Carla M.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2019, 109 (03): : 615 - 625
  • [44] Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
    Zargar, Homayoun
    Almassi, Nima
    Kovac, Evan
    Ercole, Cesar
    Remer, Erick
    Rini, Brian
    Stephenson, Andrew
    Garcia, Jorge A.
    Grivas, Petros
    BLADDER CANCER, 2017, 3 (01) : 57 - 63
  • [45] Psoas muscle mass index and peak expiratory flow as measures of sarcopenia: relation to outcomes of elderly patients with resectable esophageal cancer
    Zhang, Mingzhi
    Xiong, Yaqiong
    Chen, Mengzhou
    Xu, Dafu
    Xu, Keping
    Tian, Wenze
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [46] Sarcopenia Defined by Psoas Muscle Thickness Is Not a Predictor of Post-Operative Outcomes in IBD Patients
    Lee, Vivian
    Alipour, Omeed
    Tejura, Tapas
    Wilson, Melissa
    Memel, Zoe
    Cologne, Kyle
    Hwang, Caroline
    Shao, Ling
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1686 - S1687
  • [47] Sarcopenia Defined by Psoas Muscle Thickness is Not a Predictor of Post-Operative Outcomes in IBD Patients
    Rimsha, Chattha
    Samiha, Reza
    Mehrshad, Moradshahi
    Ma'ayan, Fadida
    Nazanin, Naddaf Dezfooli
    Zemrah, Chattha
    Yasir, Piracha
    Ruby, Mann
    Deep, Sambhi Gagan
    Karina, Samji
    Neeraj, Narula
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S4 - S4
  • [48] Psoas muscle gauge and adverse clinical outcomes in patients on hemodialysis
    Yajima, Takahiro
    Arao, Maiko
    JOURNAL OF NEPHROLOGY, 2025, : 655 - 664
  • [49] Bibliometric analysis of literature on colorectal cancer patients with sarcopenia
    Huang, Nan
    Zou, Kang
    Wang, Maoyuan
    Xiao, Li
    ASIAN JOURNAL OF SURGERY, 2024, 47 (09) : 4130 - 4131
  • [50] The choice of diagnostic modality influences the proportion of low muscle strength, low muscle mass, and sarcopenia in colorectal cancer patients
    Berg, Hedda Beate
    Alavi, Dena Treider
    Beichmann, Benedicte
    Pesonen, Maiju
    Henriksen, Christine
    Paur, Ingvild
    Bohn, Siv Kjolsrud
    Lauritzen, Peter Maehre
    Blomhoff, Rune
    Henriksen, Hege Berg
    CLINICAL NUTRITION ESPEN, 2024, 60 : 17 - 23